5-(1,3-DIOXOLAN-2-YL)-2,3,4-TRIFLUOROBENZALDEHYDE OXIME
UNII RRJ39X3LGE

Substance Identification & Data

This profile provides standardized clinical and technical data for 5-(1,3-dioxolan-2-yl)-2,3,4-trifluorobenzaldehyde Oxime, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RRJ39X3LGE.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1620459-32-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

RRJ39X3LGE

CAS Registry Number

1620459-32-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

5-(1,3-DIOXOLAN-2-YL)-2,3,4-TRIFLUOROBENZALDEHYDE OXIME

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C10H8F3NO3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ZUBCUXZOOAXQAX-LNKIKWGQSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

90284432

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O/N=C/c1cc(C2OCCO2)c(F)c(F)c1F

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 5-(1,3-dioxolan-2-yl)-2,3,4-trifluorobenzaldehyde Oxime. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.